Chromogranin a Blood Concentrations in Relation to those of Prolactin in Hormone-Refractory Metastatic Prostate Cancer: Possible Existence of Two Independent Mechanisms Responsible for Endocrine Resistance
Free accessLetterFirst published online January, 2006
Chromogranin a Blood Concentrations in Relation to those of Prolactin in Hormone-Refractory Metastatic Prostate Cancer: Possible Existence of Two Independent Mechanisms Responsible for Endocrine Resistance
BerrutiA., DogliottiL., MoscaA.Circulating neuroendocrine markers in patients with prostate carcinoma. Cancer2000; 88: 2590–7.
2.
CussenotO.Growth factors and prostatic tumors. Ann Endocrinol1997; 58: 370–80.
3.
LissoniP., BignamiA., FrontiniL.Possible involvement of prolactin in endocrine-resistant metastatic prostate cancer. Int J Biol Markers2005; 20: 123–5.
4.
LissoniP., ViganòP., VaghiM.A phase II study of tamoxifen in hormone-resistant metastatic prostate cancer: possible relation with prolactin secretion. Anticancer Res2005; 25: 3597–600.
5.
BagnatoA., CaffK.C.Endothelins as autocrine regulators of tumor cell growth. Trends Endocrinol Metab1998; 9: 378–83.
